Why West Pharmaceutical Services, Inc.’s (WST) Stock Is Up 6.38%
As of Thursday, October 29, West Pharmaceutical Services, Inc.’s WST share price has surged by 6.38%, which has investors questioning if this is right time to sell.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Life Sciences Tools & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Michael Rose
Michael Rose
Rosalio Madrigal
Michael Rose
| Share Statistics | WST | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $28,743.5 | $3,441.6 | 89% |
|
| Shares Out (Mil) | 71.3 | 105.4 | 55% |
|
| Institutional Ownership | 99.4% | 88.3% | 88% |
|
| Float (Mil) | 69.8 | 79.7 | 54% |
|
| Beta | 1.12 | 1.19 | 66% |
|
| Avg Daily Volume (000s) | 800 | 969 | 66% |
|
| Price Change (52-week) |
44.9% | 84.7% | 83% |
|
| Growth | WST | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 7.4% | 7.6% | 48% |
|
| Net Income (5yr) | 7.4% | (11.2%) | 51% |
|
| EPS (5yr) | 8.2% | 2.5% | 44 |
|
| Dividends (5yr) | 5.5% | 0.0% | 77% |
|
| Cash Flow (5yr) | 12.1% | (15.0%) | 70% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | 12 | 15 | |
| Current EPS | $2.277 | $9.450 | $10.274 | |
| Month Ago EPS | $2.272 | $8.962 | $9.983 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | $2.270 | $8.959 | $9.965 | |
| Year/Year Chg | 5.9% | 39.2% | 72.5% | |
| Financials | WST | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,327 | $800 | 68% |
|
| Net Income (TTM) (Mil) | $565 | ($31) | 80% |
|
| EPS (TTM) | $7.862 | ($0.300) | 92% |
|
| Operating Cash Flow (TTM) (Mil) | $662 | $47 | 75% |
|
| Net Cash Flow (TTM) (Mil) | ($74) | $21 | 17% |
|
| Long-Term Debt (Q1) (Mil) | $294 | $284 | 53% |
|
| Enterprise Value (Q1) (Mil) | $25,243 | $3,582 | 86% |
|
| Valuation | WST | Industry Median |
Percentile (All Stocks) |
|
| P/B | 9.72 | 3.48 | 91% |
|
| P/E | 52.8 | 38.1 | 86% |
|
| Dividend Yield | 0.2% | 0.0% | 61% |
|
| PEG (5yr hist) | 6.4 | 6.8 | 91% |
|
| Ratios | WST | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 37.6% | 47.7% | 46% |
|
| Net Margin | 18.8% | (2.6%) | 77% |
|
| ROA | 14.1% | (4.3%) | 92% |
|
| ROE | 19.1% | (7.7%) | 78% |
|
| Liabilities to Assets | 26.6% | 41.8% | 18% |
|
| F-Score | 9 | 5 | 99% |
|
West Pharmaceutical Services, Inc. did not pass any screens on 10/30/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors